1. Home >
  2. Companies >
  3. Private >
  4. Medical Products >
  5. United Kingdom >
  6. Novelion Therapeutics >
  7. M&A

Novelion Therapeutics Mergers & Acquisitions

Novelion Therapeutics M&A Summary

Novelion Therapeutics has acquired 4 companies. It has also divested 1 asset.

Novelion Therapeutics’ largest acquisition to date was in 2004, when it acquired QLT USA for $855M. Novelion Therapeutics has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity4
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Novelion Therapeutics

Novelion Therapeutics Inc.

1800-510 West Georgia Street,
Vancouver, British Columbia V6B 0M3
United Kingdom,
(877) 764-3131
www.novelion.com

All (5) Buy (4) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2019-05-21 Aegerion Pharmaceuticals, Inc. · Life Science
Cambridge, Massachusetts · www.aegerion.com

Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.

Advisor: Moelis & Co. 		- Add-on Acquisition

Amryt Pharma
Advisors: Gibson, Dunn & Crutcher , MTS Health Partners

Novelion Therapeutics


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal